Outro plans to use its $7 million in capital to expand its network of deprescribing clinicians and develop artificial intelligence clinical decision support tools.

Artificial intelligence research, products, and impact across society.

Depression, anxiety, suicide prevention, youth mental health, therapeutic approaches, neurodiversity, and access to psychiatric care.